Aims: Coronary artery disease (CAD) negatively affects prognosis in patients undergoing surgical aortic valve replacement, being currently evaluated in the most common used risk score. Our meta-analysis aims to clarify the prognostic role of CAD on mid-term survival in patients undergoing TAVI. Methods and results: Studies reporting multivariate predictors of adverse outcomes in patients undergoing TAVI were systematically searched for and pooled, when appropriate, using a random-effect method. 960 citations were first screened and finally 7 studies (2472 patients) were included. Diagnosis of CAD was reported in 52%(42–65) of patients and 1169 Edwards SAPIEN and 1303 CoreValve prostheses were implanted. After a median follow up of 452 days (357–585) 24% of patients (19–33) died, and 23 (14–32) for cardiovascular death. At pooled analysis of multivariate approach, diagnosis of coronary artery disease did not increase risk of death (OR 1.0, 95% CI, confidence interval, 0.67–1.50 I2 0%). Conclusion: CAD does not affect mid-term TAVI outcome: this finding should be weighted to accurately evaluate risk and strategies for patients with severe aortic stenosis.

Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A meta-analysis of adjusted

D'Ascenzo F;GIORDANA, Francesca;SALIZZONI, STEFANO;RINALDI, Mauro;GAITA, Fiorenzo;
2013

Abstract

Aims: Coronary artery disease (CAD) negatively affects prognosis in patients undergoing surgical aortic valve replacement, being currently evaluated in the most common used risk score. Our meta-analysis aims to clarify the prognostic role of CAD on mid-term survival in patients undergoing TAVI. Methods and results: Studies reporting multivariate predictors of adverse outcomes in patients undergoing TAVI were systematically searched for and pooled, when appropriate, using a random-effect method. 960 citations were first screened and finally 7 studies (2472 patients) were included. Diagnosis of CAD was reported in 52%(42–65) of patients and 1169 Edwards SAPIEN and 1303 CoreValve prostheses were implanted. After a median follow up of 452 days (357–585) 24% of patients (19–33) died, and 23 (14–32) for cardiovascular death. At pooled analysis of multivariate approach, diagnosis of coronary artery disease did not increase risk of death (OR 1.0, 95% CI, confidence interval, 0.67–1.50 I2 0%). Conclusion: CAD does not affect mid-term TAVI outcome: this finding should be weighted to accurately evaluate risk and strategies for patients with severe aortic stenosis.
168
3
2528
2532
D'Ascenzo F; Conrotto F; Giordana F; Moretti C; D'Amico M; Salizzoni S; Omedè P; La Torre M; Thomas M; Khawaja Z; Hildick-Smith D; Ussia G; Barbanti M; Tamburino C; Webb J; Schnabel RB; Seiffert M; Wilde S; Treede H; Gasparetto V; Napodano M; Tarantini G; Presbitero P; Mennuni M; Rossi ML; Gasparini M; Biondi Zoccai G; Lupo M; Rinaldi M; Gaita F; Marra S.
File in questo prodotto:
File Dimensione Formato  
accesso riservato.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 290.92 kB
Formato Adobe PDF
290.92 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/145117
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 89
  • ???jsp.display-item.citation.isi??? 80
social impact